Cargando…

A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy

This study aimed to compare the cancer-specific survival (CSS) and overall survival (OS) of nephrectomized patients with non-metastatic renal cell carcinoma (nmRCC) and local recurrence without distant metastasis (LR group), those with metastasis without local recurrence (MET group), and those with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Park, Boram, Hwang, Eu Chang, Hong, Sung-Hoo, Jeong, Chang Wook, Kwak, Cheol, Byun, Seok Soo, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273547/
https://www.ncbi.nlm.nih.gov/pubmed/34262859
http://dx.doi.org/10.3389/fonc.2021.653002
_version_ 1783721392330506240
author Kim, Sung Han
Park, Boram
Hwang, Eu Chang
Hong, Sung-Hoo
Jeong, Chang Wook
Kwak, Cheol
Byun, Seok Soo
Chung, Jinsoo
author_facet Kim, Sung Han
Park, Boram
Hwang, Eu Chang
Hong, Sung-Hoo
Jeong, Chang Wook
Kwak, Cheol
Byun, Seok Soo
Chung, Jinsoo
author_sort Kim, Sung Han
collection PubMed
description This study aimed to compare the cancer-specific survival (CSS) and overall survival (OS) of nephrectomized patients with non-metastatic renal cell carcinoma (nmRCC) and local recurrence without distant metastasis (LR group), those with metastasis without local recurrence (MET group), and those with both local recurrence and metastasis (BOTH group). This retrospective multicenter study included 464 curatively nephrectomized patients with nmRCC and disease recurrence between 2000 and 2012; the follow-up period was until 2017. After adjusting for significant clinicopathological factors using Cox proportional hazard models, CSS and OS were compared between the MET (n = 50, 10.7%), BOTH (n = 95, 20.5%), and LR (n = 319, 68.8%) groups. The CSS and OS rates were 34.7 and 6.5% after a median follow-up of 43.9 months, respectively. After adjusting for significant prognostic factors of OS and CSS, the MET group had hazard ratios (HRs) of 0.51 and 0.57 for OS and CSS (p = 0.039 and 0.103), respectively, whereas the BOTH group had HRs of 0.51 and 0.60 for OS and CSS (p < 0.05), respectively; LR was taken as a reference. The 2-year OS and CSS rates from the date of nephrectomy and disease recurrence were 86.9% and 88.9% and 63.5% and 67.8%, respectively, for the LR group; 89.5% and 89.5% and 48.06% and 52.43%, respectively, for the MET group; and 96.8% and 96.8% and 86.6% and 82.6%, respectively, for the BOTH group. Only the LR and BOTH groups had significant differences in the 2-year OS and CSS rates (p < 0.05). In conclusion, our study showed that the LR group had worse survival prognoses than any other group in nephrectomized patients with nmRCC.
format Online
Article
Text
id pubmed-8273547
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82735472021-07-13 A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy Kim, Sung Han Park, Boram Hwang, Eu Chang Hong, Sung-Hoo Jeong, Chang Wook Kwak, Cheol Byun, Seok Soo Chung, Jinsoo Front Oncol Oncology This study aimed to compare the cancer-specific survival (CSS) and overall survival (OS) of nephrectomized patients with non-metastatic renal cell carcinoma (nmRCC) and local recurrence without distant metastasis (LR group), those with metastasis without local recurrence (MET group), and those with both local recurrence and metastasis (BOTH group). This retrospective multicenter study included 464 curatively nephrectomized patients with nmRCC and disease recurrence between 2000 and 2012; the follow-up period was until 2017. After adjusting for significant clinicopathological factors using Cox proportional hazard models, CSS and OS were compared between the MET (n = 50, 10.7%), BOTH (n = 95, 20.5%), and LR (n = 319, 68.8%) groups. The CSS and OS rates were 34.7 and 6.5% after a median follow-up of 43.9 months, respectively. After adjusting for significant prognostic factors of OS and CSS, the MET group had hazard ratios (HRs) of 0.51 and 0.57 for OS and CSS (p = 0.039 and 0.103), respectively, whereas the BOTH group had HRs of 0.51 and 0.60 for OS and CSS (p < 0.05), respectively; LR was taken as a reference. The 2-year OS and CSS rates from the date of nephrectomy and disease recurrence were 86.9% and 88.9% and 63.5% and 67.8%, respectively, for the LR group; 89.5% and 89.5% and 48.06% and 52.43%, respectively, for the MET group; and 96.8% and 96.8% and 86.6% and 82.6%, respectively, for the BOTH group. Only the LR and BOTH groups had significant differences in the 2-year OS and CSS rates (p < 0.05). In conclusion, our study showed that the LR group had worse survival prognoses than any other group in nephrectomized patients with nmRCC. Frontiers Media S.A. 2021-06-28 /pmc/articles/PMC8273547/ /pubmed/34262859 http://dx.doi.org/10.3389/fonc.2021.653002 Text en Copyright © 2021 Kim, Park, Hwang, Hong, Jeong, Kwak, Byun and Chung https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kim, Sung Han
Park, Boram
Hwang, Eu Chang
Hong, Sung-Hoo
Jeong, Chang Wook
Kwak, Cheol
Byun, Seok Soo
Chung, Jinsoo
A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
title A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
title_full A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
title_fullStr A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
title_full_unstemmed A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
title_short A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
title_sort retrospective, multicenter, long-term follow-up analysis of the prognostic characteristics of recurring non-metastatic renal cell carcinoma after partial or radical nephrectomy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273547/
https://www.ncbi.nlm.nih.gov/pubmed/34262859
http://dx.doi.org/10.3389/fonc.2021.653002
work_keys_str_mv AT kimsunghan aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT parkboram aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT hwangeuchang aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT hongsunghoo aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT jeongchangwook aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT kwakcheol aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT byunseoksoo aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT chungjinsoo aretrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT kimsunghan retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT parkboram retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT hwangeuchang retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT hongsunghoo retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT jeongchangwook retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT kwakcheol retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT byunseoksoo retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy
AT chungjinsoo retrospectivemulticenterlongtermfollowupanalysisoftheprognosticcharacteristicsofrecurringnonmetastaticrenalcellcarcinomaafterpartialorradicalnephrectomy